Warmuth Markus — SEC Form 4 filings
SEC reporting owner CIK 1855643. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2025-01-06 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 7 filings — 49,500 shares, $951,138 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 9,500 shares @ $23.18 ($220,219) in Monte Rosa Therapeutics, Inc., filed 2026-07-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | President & CEO, Director | 8 | — | 10 legs · 49,500 sh · $951,138 | 4 |
Form 4 filings — Warmuth Markus
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 9,500 @ $23.18 | EDGAR |
| 2026-06-02 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 4,998 @ $19.41 · Sale (S): 468 @ $19.73 | EDGAR |
| 2026-05-05 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 5,467 @ $18.92 | EDGAR |
| 2026-04-15 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 8,000 @ $17.64 | EDGAR |
| 2026-03-04 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 5,466 @ $17.92 | EDGAR |
| 2026-01-09 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 3,707 @ $23.24 · Sale (S): 1,450 @ $23.88 · Sale (S): 309 @ $24.57 | EDGAR |
| 2026-01-05 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/award (A): 90,000 · Sale (S): 10,135 @ $15.17 · Grant/award (A): 406,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/award (A): 128,000 · Grant/award (A): 575,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1855643 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →